Lactic acid- Stayble Therapeutics

Drug Profile

Lactic acid- Stayble Therapeutics

Alternative Names: STA 363

Latest Information Update: 07 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Stayble Therapeutics
  • Class Analgesics; Hydroxy acids; Lactates
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Back pain

Most Recent Events

  • 07 Mar 2017 Chemical structure information added
  • 11 Jan 2017 Phase-I/II clinical trials in Back pain in Sweden (Intraspinal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top